Approval · Notice of Compliance 4457 · 1996
WINRHO SD: Notice of Compliance 4457
Issued March 1, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4457
- Date
- March 1, 1996
- Company
- Rh Pharmaceuticals Inc.Winnipeg, Manitoba, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication - immune thrombocytopenic purpura (itp)
- Therapeutic class
- Passive immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| WINRHO SD | Not yet assigned | — |
Medicinal ingredients
- ANTI-D (RH) IMMUNOGLOBULIN (HUMAN) 120 MCG per VIAL
- ANTI-D (RH) IMMUNOGLOBULIN (HUMAN) 300 MCG per VIAL